Showing results (1211-1220 of 1,264) with videos related to

Sort By:
Pageof 127
The Pharmacogenomics Journal|September 13, 2018
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthmaMelissa L Spear, Donglei Hu, Maria Pino-Yanes, et al.
The Journal of Allergy and Clinical Immunology|October 11, 2014
Genetic ancestry influences asthma susceptibility and lung function among LatinosMaria Pino-Yanes, Neeta Thakur, Christopher R Gignoux, et al.
BMJ (Clinical Research Ed.)|April 28, 2025
SPIRIT 2025 statement: updated guideline for protocols of randomised trialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2024
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium studyEyal Grunebaum, Danielle E Arnold, Brent Logan, et al.
JAMA Network Open|May 31, 2023
Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus StatementPui Y Lee, Brad A Davidson, Roshini S Abraham, et al.
Lancet (London, England)|June 15, 2026
SPIRIT 2025 statement: updated guideline for protocols of randomised trialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2012
Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European AmericansRachel A Myers, Blanca E Himes, Christopher R Gignoux, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Pageof 127